HOUSE_OVERSIGHT_024853.jpg

858 KB
View Original

Extraction Summary

1
People
6
Organizations
0
Locations
0
Events
1
Relationships
4
Quotes

Document Information

Type: Market research report / equity research page
File Size: 858 KB
Summary

This document is page 37 of a Cowen Collaborative Insights market research report dated February 25, 2019. It visually compares four CBD topical products from companies Mary's Medicinals, Curaleaf, Highline, and Reliva, noting packaging and pricing strategies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a Congressional investigation.

People (1)

Name Role Context
Michael Cella Recipient/Employee
Email address listed in the sidebar watermark indicating the report is intended for him.

Organizations (6)

Name Type Context
Cowen
Financial services firm that produced the report (Cowen Collaborative Insights).
Mary's Medicinals
Company whose product (Muscle Freeze) is analyzed in Figure 53.
Curaleaf
Company whose product (Hemp Lotion) is analyzed in Figure 54.
Highline
Company whose product (Premium CBD Cream) is analyzed in Figure 55.
Reliva
Company whose product (CBD Pain Cream) is analyzed in Figure 56.
House Oversight Committee
Implied by the Bates stamp 'HOUSE_OVERSIGHT_024853'.

Relationships (1)

Michael Cella Professional/Employment Cowen
Watermark states report is intended for michael.cella@cowen.com

Key Quotes (4)

"Mary's Provides A Range Of Topicals, Including Muscle Freeze"
Source
HOUSE_OVERSIGHT_024853.jpg
Quote #1
"Curaleaf Hemp Lotion Priced On The Premium Side"
Source
HOUSE_OVERSIGHT_024853.jpg
Quote #2
"Highline Positioned Within Mainstream"
Source
HOUSE_OVERSIGHT_024853.jpg
Quote #3
"Reliva's Pain Cream Retails For $19.99"
Source
HOUSE_OVERSIGHT_024853.jpg
Quote #4

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document